Rule 8.3 - SKYEPHARMA PLC
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note 1) BARCLAYS PLC
Company dealt in SKYEPHARMA PLC
Class of relevant security to which ORD GBP 0.10
the dealings being disclosed relate
(Note 2)
Date of dealing 14 NOVEMBER 2005
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 21,649,558 (2.86%) 8,807,710 (1.16%)
(2) Derivatives
(other than options) 10,813,938 (1.43%)
(3) Options and
agreements to 11,000 (0.00%)
purchase/sell
Total 21,660,558 (2.86%) 19,621,648 (2.59%)
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number Number
(%) (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
Purchase 253,220 0.4893
Purchase 218,167 0.4880
Purchase 260,394 0.4837
Purchase 29,386 0.5024
Sale 8,964 0.4839
Sale 17,971 0.4922
Sale 29,040 0.4978
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)
e.g. CFD
CFD Short 253,220 0.4893
CFD Short 218,167 0.4880
CFD Short 260,394 0.4837
CFD Short 29,386 0.5024
CFD Long 8,964 0.4839
CFD Long 17,971 0.4922
CFD Long 29,040 0.4978
CFD Long 301,083 0.4848
CFD Long 359,367 0.4834
CFD Long 94,694 0.4848
CFD Long 113,020 0.4834
CFD Long 386,056 0.4848
CFD Long 460,786 0.4834
CFD Long 218,167 0.4880
CFD Long 260,394 0.4834
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call option selling, securities to price American, date paid/received
purchasing, which the option European per unit
varying etc. relates (Note 7) etc. (Note 5)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit (if applicable)
(Note 5)
4. OTHER INFORMATIONS
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any
other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced. If none, this should
be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 15 NOVEMBER 2005
Contact name BARCLAYS CORPORATE SECRETARIAT
Telephone number 020 7116 2913
If a connected EFM, name of offeree/offeror with which
connected
If a connected EFM, state nature of connection (Note
10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk